Navigation Links
A new mathematical formula for cancer progression
Date:11/8/2007

Tumor progression can now be mapped less to mathematical standards and more to individual patients according to a new study by researchers at Harvard and Johns Hopkins Universities. The study, publishing in PLoS Computational Biology on November 9, 2007, provides a new paradigm in calculating tumor development, showing that it appears to be driven by mutations in many genes.

Our understanding of the progression of cancer has long been based on streamlined models where cancer is driven by mutations in only a few genes. Niko Beerenwinkel et al. show how tumor progression can be driven by hundreds of genes. As many as 20 different mutated genes might be responsible for driving an individual tumors development.

Beerenwinkel et al. used a case of colon cancer to derive their results. Cancer progression proceeds stochastically from a single genetically altered cell to billions of invasive cells through a series of clonal expansions. According to their model, cancer progression is driven by mutations in many genes, each of which confers only a small selective advantage. It was found that the time it takes for a benign tumor to transform into a malignant tumor is dominated by the selective advantage per mutation and by the number of cancer genes, whereas tumor size and mutation rate have smaller impacts.

This new model could help explain the large amount of variation between individual tumors that has long puzzled researchers and clinicians. The increasing amount of high-throughput molecular data that is being generated has resulted in new challenges for understanding complex biosystems such as cancer. New mathematical models like this one can provide unique insights that simplify interpretation and at the same time answer important biomedical questions.


'/>"/>

Contact: Mary Kohut
Press@plos.org
415-568-3460
Public Library of Science
Source:Eurekalert

1

GOOD

Page: 1

Related medicine news :

1. Eligard(R) six-month formulation successfully completes European approval procedure
2. Fingertip Formulary Mobile(TM) is Now Available for Physicians and Other Healthcare Providers Free on PDAs
3. Allure Magazine Names Remergent(R) DNA Repair Formula Best of Beauty
4. Fingertip Formulary Restrictions(TM) Provides Unprecedented Access to Real- Time Managed Care Restrictions Data
5. Equipping your Sales Force to Influence Hospital Formulary Decision-Makers
6. Martek Signs Multi-Year Infant Formula License and Supply Agreement with Alter Farmacia
7. AHRQ Expands Therapeutics Education and Research Centers and Adds New Topics: Health IT, Economics, Formularies
8. Wyeth Consumer Healthcare Announces the Availability of Centrum Cardio and New Formula Centrum Products
9. Conventional prognostic factors fail to explain better prostate cancer survival in most Asian men
10. Survival differences by race most apparent in advanced stages of breast cancer
11. MRI finds breast cancer before it becomes dangerous
Post Your Comments:
*Name:
*Comment:
*Email:
Breaking Medicine Technology:Dynatronics Receives 180-Day NASDAQ Extension 2ARKRAY, Inc. Receives FDA 510k Clearance on the Assure(R) Platinum Auto-Code Blood Glucose Monitoring System 2Berger & Montague, P.C., Files Class Action Against Hemispherx Biopharma, Inc. Extending the End of the Class Period to December 1, 2009, When the Company Announced That the FDA Found No Evidence of Efficacy of Its Drug 2Berger & Montague, P.C., Files Class Action Against Hemispherx Biopharma, Inc. Extending the End of the Class Period to December 1, 2009, When the Company Announced That the FDA Found No Evidence of Efficacy of Its Drug 3Emdeon Closes The Sentinel Group Acquisition Implements First Customer in Less than 30 Days 53708 1Emdeon Closes The Sentinel Group Acquisition Implements First Customer in Less than 30 Days 53708 2Emdeon Closes The Sentinel Group Acquisition Implements First Customer in Less than 30 Days 53708 3Emdeon Closes The Sentinel Group Acquisition Implements First Customer in Less than 30 Days 53708 4Winter Park Home to World 26apos 3Bs Foremost Producers of Large Scale Decontamination Equipment 13379 1Winter Park Home to World 26apos 3Bs Foremost Producers of Large Scale Decontamination Equipment 13379 2Lilly Broadens Income Eligibility for Patient Assistance Programs 53702 1Lilly Broadens Income Eligibility for Patient Assistance Programs 53702 2Lilly Broadens Income Eligibility for Patient Assistance Programs 53702 3